The need for innovation in development of and access to healthcare products for global health applications has never been greater, while at the same time the issues facing the developers and manufacturers have never been more complicated.

​

Developing and distributing medicines and vaccines for a global market involves expanded challenges and issues for the parties involved.  Done well, these developments are smooth alliances between multi-functional organizations funded by both public and private organizations.  Optimally, the resulting products benefit not just traditional markets but also those in less developed countries and regions.  In order to achieve these goals, certain elements are essential:

• Innovation

• Development capabilities

• Funding sources

• Global clinical trials

• The strategic and social use of intellectual property

• Alliance capabilities

• Distribution networks
   

Join the Global Health Innovation Alliance Accelerator and the Triangle Global Health Consortium on April 4th for a workshop exploring the concerns facing start up companies, spin-offs from universities, institutes, the US government and traditional pharmaceutical companies as they partner to develop and distribute new medicines and vaccines.

Attendees will gain practical skills and knowledge on a broad range of issues, including meeting requirements for partnering with the NIH, foundations, and clinical trial organizations; negotiating license agreements; and managing clinical trials in low and middle income countries.  Networking opportunities will be incorporated throughout the day.